“johnson-johnson” Archives

in
Entry Author Date Location
Fred Lee, The UW Radiologist With Startup Vision 06/29/16 Wisconsin
OrthoPediatrics Bones Up on IPO for Children’s Medical Devices 06/20/16 Indiana
Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies 06/06/16 Boston
Wantable, Gener8tor, and Arrowhead: This Week’s Wisconsin Watchlist 03/14/16 Wisconsin
NeuWave Bought by J&J Subsidiary Ethicon, Eyes International Markets 03/10/16 Wisconsin
With $48M For Petra Pharma, Accelerator Places First NYC Bet 01/06/16 New York
East Coast Biotech Roundup: Emulate, Pulmatrix, Synergy & More 06/19/15 New York
With J&J Deal, Emulate Nabs First Partner For Organ on Chip Tech 06/18/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Innocrin Pharmaceuticals Lands $28M for Prostate, Breast Cancer Trials 04/15/15 Raleigh Durham
Xconomy Boston’s Top Stories of Q1 2015: Editor’s Picks 04/01/15 Boston
Novartis Bets $250M-Plus on Aduro’s Immuno-Oncology Work 03/30/15 San Francisco
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
West Coast Biotech Roundup: Amgen/deCODE, Calico, Orexigen & More 03/27/15 San Diego
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline 03/20/15 Boston
West Coast Biotech Roundup: Apple, 23andMe, Amgen, Acadia & More 03/13/15 San Francisco
After Raising $60M, Kura Oncology Renews Work on Shelved Cancer Drug 03/12/15 San Diego
East Coast Biotech Roundup: Varmus, Bristol, Aerie, Aura & More 03/06/15 Boston
AbbVie Snaps up Pharmacyclics, Pays Whopping $21B For Cancer Drug 03/05/15 National
Vascular Pharmaceuticals Lands $9M For Diabetes Drug Trials 03/03/15 Raleigh Durham
Tiger Teams, Dropping Subs, and Biotech’s Elusive Second Strikes 03/03/15 National
East Coast Biotech Roundup: Vertex, Syndax, Build-to-Buy Deals & More 02/20/15 Boston
Seragon CEO Rich Heyman Is Going on Hiatus 02/20/15 San Diego
Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M 01/28/15 Boston
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
East Coast Biotech Roundup: Foundation, Biogen, Moderna, & Lots More 01/16/15 Boston
With Vedanta Deal, J&J Marks Big-Pharma Milestone in the Microbiome 01/13/15 Boston
Genentech Redux? Roche Buys Majority Stake in Foundation Medicine 01/12/15 Boston
Page 1 of 12 next page »